Edgewise Therapeutics Inc.
EWTX | NASDAQ
$44.64
-$0.68 (-1.50%)
At close: Sep 21, 2026, 4:00 PM ET
$44.79
+$0.15 (+0.34%)
Pre-market:
Sep 22, 2026, 5:31 AM ET
Market Data
Market Cap $4.88B
Enterprise Value $4.35B
Beta 0.28
Average Volume 1.37M
Shares Outstanding (Diluted) 107.67M
Shares Change YoY 2.6%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US28036F1057
Price Performance
Price Change 1M 1.6%
Price Change 3M 15.0%
Price Change 6M 39.8%
Price Change YTD 88.0%
Price Change 1Y 195.6%
Price Change 3Y 645.2%
Price Change 5Y 145.4%
1M CAGR (ann.) 2.0%
1Y CAGR (ann.) 226.3%
5Y CAGR (ann.) 23.0%
All-Time CAGR 7.8%
Valuation
PE Ratio -24.13
Forward PE N/A
PEG Ratio 1.40
Forward PEG 1.21
PS Ratio N/A
Forward PS 124.30
PB Ratio 10.72
P/FCF Ratio -30.09
P/Adj. FCF Ratio -29.85
P/OCF Ratio -30.16
EV/Sales N/A
EV/EBIT -22.04
EV/EBITDA -22.04
EV/FCF -27.23
Earnings Yield -4.1%
FCF Yield -3.3%
Adj. FCF Yield -3.4%
Financial Health
Net Cash $460.71M
Total Debt $3.59M
Cash & Short-Term Investments $460.71M
Total Assets $479.69M
Current Ratio 16.24
Quick Ratio 16.24
Debt / Equity Ratio 0.01
Debt / EBITDA -0.02
Debt / FCF -0.02
OCF / Debt -44.41
Interest Coverage 0.00
Altman Z-Score 90.40
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -0.8%
Returns
Return on Assets -41.1%
Return on Equity -39.0%
Return on Invested Capital -48.5%
Return on Capital Employed -48.6%
Return on Tangible Assets -41.1%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -9.1%
EPS CAGR 5Y -12.0%
EPS CAGR 10Y N/A
FCF CAGR 3Y -21.1%
FCF CAGR 5Y -26.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y 10.3%
Revenue Growth Next 3Y N/A
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.55
EPS Growth Est (next Q) 41.0%
Revenue Est (next Q) $129.17M
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $51.90
Price Target Upside 16.3%
Cash Flow
Operating Cash Flow $-159.42M
Free Cash Flow $-159.62M
Adj. Free Cash Flow $-160.9M
FCF Per Share -$1.48
OCF Per Share -$1.48
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-590K
Operating Income $-218.9M
EBITDA $-197.21M
Net Income $-197.22M
EPS (Diluted) -$1.85
Revenue / Employee N/A
Profit / Employee $-1.55M
Employees 127
Add to Watchlist
Select watchlists to add or remove EWTX